Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease

被引:40
|
作者
Escande, Mariela V. [1 ,2 ]
Taravini, Irene R. E. [3 ,4 ,5 ]
Zold, Camila L. [1 ,2 ]
Belforte, Juan E. [1 ,2 ]
Gustavo Murer, M. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, IFIBIO Bernardo Houssay, Syst Neurosci Grp, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, RA-1121 Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, ININFA, Expt Parkinsonism Grp, RA-1121 Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, RA-1121 Buenos Aires, DF, Argentina
[5] Univ Entre Rios, Expt Neurobiol Lab, RA-2820 Concepcion Del Uruguay, Entre Rios, Argentina
关键词
6-OHDA; functional connectivity; in vivo electrophysiology; medium spiny neurons; striatum; STRIATAL PROJECTION NEURONS; MEDIUM SPINY NEURONS; EXTERNAL GLOBUS-PALLIDUS; BAC TRANSGENIC MICE; BASAL GANGLIA; IN-VIVO; STRIATOPALLIDAL NEURONS; L-DOPA; FEEDFORWARD INHIBITION; NIGROSTRIATAL DAMAGE;
D O I
10.1523/JNEUROSCI.0492-15.2016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristic slowness of movement in Parkinson's disease relates to an imbalance in the activity of striatal medium spiny neurons (MSNs) of the direct (dMSNs) and indirect (iMSNs) pathways. However, it is still unclear whether this imbalance emerges during the asymptomatic phase of the disease or if it correlates with symptom severity. Here, we have used in vivo juxtacellular recordings and transgenic mice showing MSN-type-specific expression of fluorescent proteins to examine striatal imbalance after lesioning dopaminergic neurons of the substantia nigra. Multivariate clustering analysis of behavioral data discriminated 2 groups of dopamine-lesioned mice: asymptomatic (42 +/- 7% dopaminergic neuron loss) and symptomatic (85 +/- 5% cell loss). Contrary to the view that both pathways have similar gain in control conditions, dMSNs respond more intensely than iMSNs to cortical inputs in control animals. Importantly, asymptomatic mice show significant functional disconnection of dMSNs from motor cortex without changes in iMSN connectivity. Moreover, not only the gain but also the timing of the pathways is altered in symptomatic parkinsonism, where iMSNs fire significantly more and earlier than dMSNs. Therefore, cortical drive to dMSNs decreases after partial nigrostriatal lesions producing no behavioral impairment, but additional alterations in the gain and timing of iMSNs characterize symptomatic rodent parkinsonism.
引用
收藏
页码:5686 / 5698
页数:13
相关论文
共 50 条
  • [31] Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson's disease
    Gramage, Esther
    Saiz, Jorge
    Fernandez-Calle, Rosalia
    Martin, Yasmina B.
    Uribarri, Maria
    Ferrer-Alcon, Marcel
    Barbas, Coral
    Herradon, Gonzalo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] Effects of eugenol on the behavioral and pathological progression in the MPTP-induced Parkinson's disease mouse model
    Vora, Urmi
    Vyas, Vivek Kumar
    Wal, Pranay
    Saxena, Bhagawati
    DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (04) : 154 - 163
  • [33] Loss of Non-Apoptotic Role of Caspase-3 in the PINK1 Mouse Model of Parkinson's Disease
    Imbriani, Paola
    Tassone, Annalisa
    Meringolo, Maria
    Ponterio, Giulia
    Madeo, Graziella
    Pisani, Antonio
    Bonsi, Paola
    Martella, Giuseppina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [34] Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
    Ghosh, Anamitra
    Roy, Avik
    Matras, Joanna
    Brahmachari, Saurav
    Gendelman, Howard E.
    Pahan, Kalipada
    JOURNAL OF NEUROSCIENCE, 2009, 29 (43) : 13543 - 13556
  • [35] Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease
    Schintu, Nicoletta
    Frau, Lucia
    Ibba, Marcello
    Garau, Arianna
    Carboni, Ezio
    Carta, Anna R.
    NEUROTOXICITY RESEARCH, 2009, 16 (02) : 127 - 139
  • [36] Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease
    Bourque, Melanie
    Morissette, Marc
    Cote, Melissa
    Soulet, Denis
    Di Paolo, Therese
    NEUROBIOLOGY OF AGING, 2013, 34 (03) : 887 - 901
  • [37] Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease
    Rosa, Alexandra Isabel
    Duarte-Silva, Sara
    Silva-Fernandes, Anabela
    Nunes, Maria Joao
    Carvalho, Andreia Neves
    Rodrigues, Elsa
    Gama, Maria Joao
    Pereira Rodrigues, Cecilia Maria
    Maciel, Patricia
    Castro-Caldas, Margarida
    MOLECULAR NEUROBIOLOGY, 2018, 55 (12) : 9139 - 9155
  • [38] The Antioxidative Effect of Electro-Acupuncture in a Mouse Model of Parkinson's Disease
    Wang, Haomin
    Pan, Yanli
    Xue, Bing
    Wang, Xinhong
    Zhao, Feng
    Jia, Jun
    Liang, Xibin
    Wang, Xiaomin
    PLOS ONE, 2011, 6 (05):
  • [39] Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease
    Nicoletta Schintu
    Lucia Frau
    Marcello Ibba
    Arianna Garau
    Ezio Carboni
    Anna R. Carta
    Neurotoxicity Research, 2009, 16 : 127 - 139
  • [40] The Gut and Parkinson's Disease - A Bidirectional Pathway
    Santos, Susanne Fonseca
    de Oliveira, Hadassa Loth
    Yamada, Elizabeth Sumi
    Neves, Bianca Cruz
    Pereira Jr, Antonio
    FRONTIERS IN NEUROLOGY, 2019, 10